Adamis Pharmaceuticals reported 15.9M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Adamis Pharmaceuticals ADMP:US 15.9M 9.98M
Adma Biologics ADMA:US $ 126.93M 14.24M
Brainstorm Cell Therapeutics BCLI:US $ 14.49M 4.86M
Cara Therapeutics CARA:US $ 204.11M 23.41M
Cerulean Pharma CERU:US $ 30.88M 7.88M
Glaxosmithkline GSK:US $ 16181M 1126M
GlaxoSmithKline GSK:LN 16181M 1126M
Merk MRK:US $ 40883M 2699M
Pfizer PFE:US $ 82424M 5224M
Redhill Biopharma RDHL:US $ -5.24M 14.12M